Benev­o­len­tAI re­struc­tures; Cimeio, Ky­owa ink cell ther­a­py deal

Plus, news about NewAms­ter­dam, Rock­et, Im­mu­ni­ty­Bio, CG On­col­o­gy, Spruce Bio­sciences, Pharm­ing, Ve­r­a­der­mics, Noe­ma Phar­ma, Am­brosia Bio­sciences, Es­o­Biotec, Cel­lec­tar Bio­sciences and He­p­i­on:

Benev­o­len­tAI’s over­haul: The strug­gling …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER